WEGOVY 1.7MG PREFILLED PEN 1S

Wegovy 1.7mg Injection (Semaglutide) Quick Answer: Wegovy 1.7mg Injection contains Semaglutide, a GLP-1 receptor agonist made by Novo Nordisk and imported into Pakistan. This is usually the fourth escalation step, used from around week 13 onward - after tolerating the 0.25mg, 0.5mg, and 1mg doses - before reaching the standard 2.4mg maintenance dose. For patients who don't tolerate 2.4mg, 1.7mg instead becomes their long-term maintenance dose. It's a once-weekly subcutaneous injection costing around Rs. 54,218 per pen at Dawa Healthcare, though pricing and stock may change. 📌 Note: Depending on your treatment plan, 1.7mg is either an escalation (titration) step on the way to the 2.4mg maintenance dose, or - for patients who do not tolerate 2.4mg - the maintenance dose itself. Confirm with your doctor which applies to you. Key Takeaways · Active Ingredient: Semaglutide 1.7mg per prefilled pen - a GLP-1 receptor agonist · Main Uses: weight management in adults with obesity or overweight (with diet & exercise); cardiovascular risk reduction in adults with heart disease and obesity or overweight · Dose Role: Fourth escalation step, or maintenance dose for some patients - usually from week 13 onward as the last step before 2.4mg; if 2.4mg isn't tolerated, 1.7mg can become the long-term maintenance dose · Frequency: once-weekly subcutaneous injection · Access: prescription required; not an over-the-counter medicine · Price: ~Rs. 54,218 per pen at Dawa Healthcare (subject to change) 📋 Product Specifications Field Detail Generic Name Semaglutide 1.7mg Manufacturer Novo Nordisk (imported) Pack Size Prefilled Pen (FlexTouch - Multi-Dose, 4 Weekly Doses per Pen) Drug Class GLP-1 Receptor Agonist (Incretin Mimetic) Dosage Form Subcutaneous Injection (Pen) Dose Role Fourth escalation step, or maintenance dose for some patients Price in Pakistan Around Rs. 54,218 per Pen at Dawa Healthcare (Subject to Change) Availability In Stock (Very Limited Quantity - Confirm Availability Before Ordering) Storage Refrigerated 2-8°C Before First Use - See Storage Section for Details Prescription Required Yes, Prescription-Only Medicine Delivery Area Karachi Only (Cold-Chain / Injectable Item) How Wegovy Works Semaglutide, Wegovy's active ingredient, is a GLP-1 (glucagon-like peptide-1) receptor agonist. It mimics a natural gut hormone that signals fullness to the brain, slows stomach emptying, and helps regulate blood sugar - reducing appetite and food intake. This is why Semaglutide supports meaningful weight loss when combined with a reduced-calorie diet and more physical activity. Always follow the dose and schedule set by your doctor. Wegovy Uses Wegovy 1.7mg Injection is used for: · Chronic Weight Management: supports weight loss in adults with obesity or overweight, alongside a reduced-calorie diet and exercise · Cardiovascular Risk Reduction: lowers the risk of major cardiovascular events (e.g., heart attack or stroke) in adults with established cardiovascular disease and obesity or overweight · Other Uses: in some markets, Wegovy is also used in adolescents aged 12 and older with obesity, and for certain adults with fatty liver disease (MASH) These uses reflect Wegovy's internationally approved prescribing information (e.g., the US FDA label). Approved indications vary by country, so confirm with your doctor or pharmacist what applies in Pakistan before starting. Wegovy is meant for long-term use under medical supervision, with periodic review by your doctor. Who Should Use Wegovy Wegovy is generally prescribed for adults with obesity, or who are overweight with at least one weight-related condition, who need help managing their weight - or for adults with established cardiovascular disease and obesity or overweight - and who have been assessed by a doctor as suitable for GLP-1 therapy. 🚫 Who Should Avoid It Avoid Wegovy, or use it only under close medical advice, if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), a known allergy to Semaglutide or any pen component, or severe gastroparesis. If pregnant, planning pregnancy, or breastfeeding, discuss the risks and alternatives with your doctor, as pregnancy safety data is limited. A history of pancreatitis, diabetic retinopathy, or a heart rate/rhythm problem also warrants careful assessment before starting, and Wegovy should not be combined with other GLP-1 or GIP-based medicines. Can It Be Taken Long Term? Yes - Wegovy is typically an ongoing, long-term treatment for weight management or cardiovascular risk reduction, for as long as your doctor advises and you tolerate it well. Your doctor will periodically review your weight, cardiovascular risk factors, and side effects to decide whether to continue, adjust, or stop treatment. 🛡️ Precautions and Drug Interactions · Insulin or Sulfonylureas: combining these with Wegovy increases the risk of low blood sugar; your doctor may need to lower their dose · Oral Medicines: Wegovy slows stomach emptying, which can affect how quickly other oral medicines are absorbed - tell your doctor about all medicines you take · Surgery or Anaesthesia: tell your doctor and anaesthetist that you are using Wegovy before any procedure requiring general anaesthesia or deep sedation, due to a risk of pulmonary aspiration · Alcohol: may worsen nausea and other gastrointestinal side effects · Existing Conditions: tell your doctor about any history of pancreatitis, gallbladder disease, kidney disease, diabetic eye disease (retinopathy), or heart rhythm problems before starting ❄️ Storage Before first use, refrigerate Wegovy pens at 2-8°C (away from the cooling element; do not freeze) and keep them capped in the original carton, away from light. After first use, keep the pen below 30°C or refrigerated, cap on, for up to 6 weeks. Each FlexTouch pen holds 4 doses - dispose of it once all doses are used, 6 weeks have passed, or it expires, whichever comes first. Keep out of children's reach and sight, and dispose of used pens in a sharps container, never household rubbish. 💰 Wegovy 1.7mg Price in Pakistan Wegovy 1.7mg is available through Dawa Healthcare, with delivery limited to Karachi for cold-chain/injectable items. On receipt, check the batch number, expiry date, and tamper-evident seal against the manufacturer's packaging, and contact the pharmacy with any concerns. Current pricing for all strengths is listed below. All Wegovy Strengths & Prices Strength Price at Dawa Healthcare Wegovy 0.25mg (Green) Rs. 30,349 Wegovy 0.5mg (Pink) Rs. 30,349 Wegovy 1mg (Brown) Rs. 30,348 Wegovy 1.7mg Rs. 54,218 ❓ Frequently Asked Questions What is Wegovy 1.7mg used for? Wegovy 1.7mg Injection contains Semaglutide and is used, together with a reduced-calorie diet and increased physical activity, for chronic weight management in adults who are overweight or living with obesity. It is also used to reduce the risk of major cardiovascular events in adults with known heart disease who are overweight or obese. Is Wegovy 1.7mg the starting dose or a later dose? Wegovy 1.7mg has two possible roles. For most patients it is the fourth and final escalation (titration) step, usually started around week 13 after 4 weeks each on the 0.25mg, 0.5mg, and 1mg doses, before moving up to the 2.4mg maintenance dose. For patients who do not tolerate 2.4mg well, 1.7mg can instead become their long-term maintenance dose. Ask your doctor which applies to you. What is the correct dose of Wegovy? Wegovy is injected once weekly under the skin. Treatment starts at 0.25mg and is increased by a doctor roughly every 4 weeks - to 0.5mg, then 1mg, then 1.7mg - over a 16-week escalation (titration) phase. After that, maintenance dosing is either 1.7mg or 2.4mg weekly, depending on tolerance. A higher 7.2mg dose (Wegovy HD) was FDA-approved in the United States in March 2026 as a step-up option for patients who have not achieved sufficient weight loss on 2.4mg; ask your doctor whether it is relevant and available for you. What is the difference between an escalation dose and a maintenance dose? Escalation (titration) doses - 0.25mg, 0.5mg, 1mg, and usually 1.7mg - are used one after another over the first 16 weeks to let the body adjust and reduce side effects; they are not meant to be continued indefinitely. The maintenance dose (1.7mg or 2.4mg, chosen by your doctor based on tolerance) is the dose you generally stay on long-term for ongoing weight management. Is a prescription required to buy Wegovy 1.7mg? Yes, Wegovy is a prescription-only medicine. A valid prescription must be uploaded to order it. What are the side effects of Wegovy? The most common side effects are nausea, diarrhoea, vomiting, constipation, abdominal pain, headache, and fatigue. Serious but less common risks include pancreatitis, gallbladder problems, kidney injury, and low blood sugar when combined with insulin or sulfonylureas. Who should avoid Wegovy? Avoid it, or seek medical advice first, if you or a family member has a history of medullary thyroid carcinoma or MEN 2, if you have severe gastroparesis, or if you are pregnant or breastfeeding. How is Wegovy 1.7mg injected? Wegovy is injected subcutaneously into the abdomen, thigh, or upper arm, once a week on the same day, with or without food. Each FlexTouch pen contains 4 weekly doses - listen for two clicks and check the dose counter to confirm the full dose has been delivered. What happens if I miss a dose of Wegovy? If your next scheduled dose is more than 48 hours away, take the missed dose as soon as possible. If it is less than 48 hours away, skip the missed dose and take your next dose on the regular scheduled day. How should Wegovy be stored? Before first use, store refrigerated at 2-8°C. After first use, the pen can be kept for up to 6 weeks below 30°C or refrigerated, with the cap on to protect it from light. Do not freeze. What is the price of Wegovy 1.7mg in Pakistan? At Dawa Healthcare, the Wegovy 1.7mg pen costs around Rs. 54,218 per pen, though prices and stock availability can change without notice. How is Wegovy different from Zeptide? Both are once-weekly injectable weight-management medicines, but they contain different active ingredients. Wegovy contains Semaglutide, a GLP-1-only receptor agonist made by Novo Nordisk and imported into Pakistan, while Zeptide contains Tirzepatide, a dual GIP/GLP-1 receptor agonist manufactured locally by Ferozsons Laboratories.